Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery

D. Dake, Michael; M. Ansel, Gary; R. Jaff, Michael; Ohki, Takao; R. Saxon, Richard; Bob Smouse, H.; Machan, Lindsay; Snyder, S.A.; E. O’Leary, Erin; Ragheb, Anthony; Zeller, Thomas

doi:10.1161/circulationaha.115.016900

Public

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery

Published in Circulation • Mar 12, 2016

Authors:

Michael D. Dake

Gary M. Ansel

Michael R. Jaff

Abstract

BACKGROUND: This randomized controlled trial evaluated clinical durability of Zilver PTX, a paclitaxel-coated drug-eluting stent (DES), for femoropopliteal artery lesions. Outcomes compare primary DES versus percutaneous transluminal angioplasty (PTA), overall DES (primary and provisional) versus st...

Subject

Medicine

Restenosis

Revascularization

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!